A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Purpose of the study is to test whether adalimumab can induce clinical remission in subjects
with active Crohn's disease when compared to placebo (an inactive substance)